We are live on ! Find out more
CRDL

Cardiol Therapeutics
CRDL

33 hedge funds and large institutions have $10.7M invested in Cardiol Therapeutics in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,400% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 1

594% more call options, than puts

Call options by funds: $2.05M | Put options by funds: $296K

74% more funds holding

Funds holding: 19 → 33 (+14)

62% more capital invested

Capital invested by funds: $6.62M → $10.7M (+$4.1M)

5.78% more ownership

Funds ownership: 3.74% → 9.52% (+5.8%)

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

Holders
33
Holders Change
+14
Holders Change %
+73.68%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
7
Reduced
8
Closed
1
Calls
$2.05M
Puts
$296K
Net Calls
+$1.76M
Net Calls Change
+$1.76M

Top Buyers

Rank Fund Capital Flow
1
MI
MMCAP International
Cayman Islands
+$8.71M
2
Verition Fund Management
Verition Fund Management
Connecticut
+$1.26M
3
Two Sigma Investments
Two Sigma Investments
New York
+$537K
4
Citadel Advisors
Citadel Advisors
Florida
+$489K
5
Goldman Sachs
Goldman Sachs
New York
+$296K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$168K
2
Renaissance Technologies
Renaissance Technologies
New York
-$143K
3
Jane Street
Jane Street
New York
-$73.6K
4
Morgan Stanley
Morgan Stanley
New York
-$49.8K
5
Bank of America
Bank of America
North Carolina
-$34.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
MI
1
MMCAP International
Cayman Islands
$5.83M +$8.71M +3,153,200 New
Mirae Asset Global Investments
2
Mirae Asset Global Investments
South Korea
$1.93M +$4.15K +1,501 +0.1%
Verition Fund Management
3
Verition Fund Management
Connecticut
$847K +$1.26M +457,732 New
Two Sigma Investments
4
Two Sigma Investments
New York
$360K +$537K +194,554 New
Citadel Advisors
5
Citadel Advisors
Florida
$328K +$489K +177,069 New
Goldman Sachs
6
Goldman Sachs
New York
$233K +$296K +107,000 +560%
Two Sigma Advisers
7
Two Sigma Advisers
New York
$229K +$255K +92,500 +297%
SM
8
Sabby Management
Florida
$184K +$275K +99,440 New
Renaissance Technologies
9
Renaissance Technologies
New York
$171K -$143K -51,900 -36%
Jane Street
10
Jane Street
New York
$97K -$73.6K -26,635 -34%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$97K – – –
VIA
12
Vident Investment Advisory
Georgia
$97K +$5.74K +2,079 +4%
Belvedere Trading
13
Belvedere Trading
Illinois
$49K +$74.7K +27,032 New
MHIC
14
Marble Harbor Investment Counsel
Massachusetts
$42K +$2.49K +900 +4%
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$39K +$19.3K +6,999 +49%
PO
16
Private Ocean
California
$38K +$41.8K +15,151 +275%
VF
17
Virtu Financial
New York
$27K -$168K -61,007 -80%
BCM
18
Brookstone Capital Management
Illinois
$27K +$43.9K +15,887 New
TSS
19
Two Sigma Securities
New York
$21K +$31.2K +11,280 New
Morgan Stanley
20
Morgan Stanley
New York
$17K -$49.8K -18,039 -67%
TWC
21
TD Waterhouse Canada
Ontario, Canada
$15.8K +$19.1K +6,900 New
FDCDDQ
22
Federation des caisses Desjardins du Quebec
Quebec, Canada
$11K – – –
UBS Group
23
UBS Group
Switzerland
$10K +$14.8K +5,367 New
Osaic Holdings
24
Osaic Holdings
Arizona
$9K -$30.3K -10,970 -69%
VNA
25
Valley National Advisers
Pennsylvania
$9K +$13.8K +5,000 New
1
2

CRDL Hedge Fund Activity: Q4 2021 in Review

33 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Cardiol Therapeutics (CRDL) for Q4 2021, worth a combined $10.7M — up 62% from $6.62M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new CRDL positions and 1 closed out — a net gain of 14 holders — while 7 added to existing stakes and 8 trimmed.

The largest buyer was MMCAP International, opening a new position worth an estimated $8.71M. The largest seller was Virtu Financial, cutting an estimated $168K.

  • 33 institutional investors held Cardiol Therapeutics (CRDL) as of Q4 2021, up from 19 in Q3 2021.
  • Funds reported $10.7M of Cardiol Therapeutics stock for Q4 2021, up 62% quarter-over-quarter.
  • 15 funds opened new Cardiol Therapeutics positions in Q4 2021 and 1 closed out, a net change of +14 holders.
  • The largest Cardiol Therapeutics buyer in Q4 2021 was MMCAP International, an estimated $8.71M added.
  • The largest Cardiol Therapeutics seller in Q4 2021 was Virtu Financial, an estimated $168K sold.

Based on aggregated 13F filings for Q4 2021.